Hours after Vij tested positive for the coronavirus disease, the pharmaceutical company manufacturing the potential vaccine against coronavirus clarified that the shot is meant to be protective only two weeks after the second dose – which is given after a gap of 28 days following the first dose.
![]() |
Haryana health minister Anil Vij participating in the third phase trial of the Covid-19 vaccine at Civil Hospital, Ambala Cantonment on November 20, 2020.(HT Photo ) |
“It is a double-blind trial (meaning, neither the recipient nor the researchers know who is given a vaccine and who is given a placebo). Such trials have a very rigorous protocol for unblinding,” a Union health ministry official said asking not to be named.
“Before administering Covaxin, doctors told me that antibodies will develop after 14 days of the second dose... I am being treated at a civil hospital and I feel fine. It has only been 14 days since I got the first shot,” Vij wrote on Twitter in Hindi.
मुझे कोवेक्सिन लगाने से पहले डॉक्टरों ने बता दिया था कि वेक्सिन दूसरी डोज 28 दिन के बाद लगने के 14 दिन बाद ही अन्टोबोडी बनेगी । पूरी एहतियात बरतने के बाद भी मैंकरना के काबू आगया । मेरा सिविल हस्पताल में इलाज हो रहा है ओर मैं ठीक महसूस कर रहा हूँ ।
— ANIL VIJ MINISTER HARYANA (@anilvijminister) December 6, 2020
The minister’s tweet comes after his illness and participation in the trial for Bharat Biotech International Limited’s Covaxin triggered confusion over the vaccine on Saturday. Hours after Vij tested positive for the coronavirus disease, the pharmaceutical company clarified that the shot is meant to be protective only two weeks after the second dose – which is given after a gap of 28 days following the first dose.
Later, the minister himself addressed the concerns by issuing a similar statement to news agency PTI.
“I was told that antibodies start to develop after the second dose, which is administered after 28 days of getting the first shot. And full antibodies are developed 14 days after the second dose is given. So, the complete cycle takes 42 days. In between there is no protection,” Vij told PTI over the phone.
Developed by Bharat Biotech in collaboration with the government’s National Institute of Virology, Covaxin is a two-dose vaccine. It uses an inactivated virus to elicit an immune response in people.The third phase trials of the potential vaccine against coronavirus disease is currently being conducted with over 25,000 volunteers across 25 centres in the country.
comment 0 Comments
more_vert